Not logged in, please login to view portfolio!



GLAXO Share Price | GlaxoSmithKline Pakistan Limited

GLAXO Share Price History

GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,ALLSHR,KMIALLSHR,KSE100. GLAXO share price / stock price today is 91.83 PKR. Today volume traded in GLAXO is 128 K, price change is 1.44%, high price is 92.90 PKR, and low price is 91.00 PKR.

GLAXO Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return -2.31% 8.93% 12.02% 16.09% 20.2%

Company Snapshot

loading
GLAXO
2024-04-17 16:06:27
Current
91.83
Change
1.30
Change %
1.44%
Volume
128000.00
Price to Earnings Ratio
54.66
Earning per Share
1.68
Book Value
65.01
Price to Book
1.28
Market Cap
29.24 B
Dividend
0.00
Dividend Yield (%)
0.00 %
Debt to Equity
0.00
Net Profit Margin
1.08 %
Gross Profit Margin
7.05 %
Current Ratio
1.58
Face Value
10.00
Shares
318.47 M
FreeFloat
63.69 M
Free Float %
20.00
Equity to Asset(%)
52.85
Interest
35.56
Beta
1.005
Upper/Lower Cap
97.32 / 83.74
Times-Revenue Method New
52 Week High
97.50
52 Week Low
68.00
High
92.90
Low
91.00
Previous
90.53
Company Financials
Company Announcements
Date Announce Title Attachments
2024-04-03 GLAXO | GlaxoSmithKline Pakistan Limited - Notice of Annual General Meeting PDF
2024-04-03 Transmission of Annual Report for the year ended December 31, 2023 View PDF
2024-03-26 GLAXO | GlaxoSmithKline Pakistan Limited FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 - GLAXO PDF
2024-03-19 Board of Directors Meeting - 4th Quarter 2023 on 26 March 2024 View PDF
2023-12-13 Presentation of Corporate Briefing Session - 2023 View PDF
2023-12-11 GLAXO | GlaxoSmithKline Pakistan Limited- CORPORATE BRIEFING SESSION - 2023 PDF
2023-10-30 Tranmission of Quarterly Report for the Period Ended September 30, 2023 View PDF
2023-10-24 Financial Results for the Quarter Ended 30-09-2023 PDF
2023-10-17 Board Of Directors Meeting View PDF
2023-08-28 Transmission of Quarterly Report for the Period Ended June 30, 2023 View PDF
2023-08-22 GLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30, 2023 PDF
2023-08-15 Board Meeting View PDF
2023-06-02 Change of Company Secretary View PDF
2023-06-02 Material informaiton View PDF
2023-05-30 Material Information - Resignation of Company Secretary View PDF
2023-05-24 Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on May 24, 2023 View PDF
2023-05-17 Notice of Election of Directors View PDF
2023-05-03 Transmission of Annual Report for the Year Ended December 31, 2022 View PDF
2023-05-03 Notice of Annual General Meeting View PDF
2023-04-28 Transmission of Quarterly Report for the Period Ended March 31, 2023 View PDF
2023-04-27 Financial Results For The Quarter Ended March 31, 2023 View PDF
2023-04-20 Board of Directors Meeting View PDF
2023-04-20 Notice of Annual General Meeting - Prior Publication View PDF
2023-04-05 RESCHEDULING OF AGM AND BOOK CLOSURE DATES View PDF
2023-03-27 Approval of Extension in Time for Holding the Annual General Meeting View PDF
2023-03-17 Applied for Extension for Holding AGM for the Year ended 2022-12-31 View PDF
2023-02-09 Financial Results for the Year Ended December 31, 2022 View PDF
2023-02-02 Board Meeting - 4th Quarter 2022 on 9 February 2023 View PDF
2022-11-24 Notice of Corporate Briefing Session 2022 View PDF
2022-10-28 Transmission of Quarterly Report for the Period Ended September 30, 2022 View PDF
2022-10-25 Financial Results for the Quarter Ended September 30, 2022 View PDF
2022-10-18 Board Meeting View PDF
2022-09-28 Appointment of Non-Executive Director View PDF
2022-09-28 Appointment of Non-Executive Director View PDF
2022-09-16 GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information REVOKED PDF
2022-09-16 GLAXO | GlaxoSmithKline Pakistan Limited REVISED PDF
2022-09-16 GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information PDF
2022-08-29 Transmission of Quarterly Report for the Period Ended June 30, 2022 View PDF
2022-08-23 Financial Results for the Quarter Ended June 30, 2022 View PDF
2022-08-16 Board of Directors Meeting - August 23, 2022 View PDF
2022-08-12 Appointment of Ms. Lai Kuen Goh - Chairperson and Non-Executive Director View PDF
2022-08-10 Resignation of Mr. Dmytro Oliinyk from the Board of GlaxoSmithKline Pakistan Limited View PDF
2022-06-30 Material Information - Resignation of Mark Dawson as Director w.e.f. 30 June 2022 View PDF
2022-06-08 Material Information View PDF
2022-05-10 Credit of Final Cash Dividend 2021 View PDF
2022-05-06 PRIOR PUBLICAITON NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View PDF
2022-05-06 Transmission of Quarterly Report for the Period Ended March 31, 2022 View PDF
2022-04-26 Financial Results for the Quarter Ended March 31, 2022 View PDF
2022-04-25 Board Meeting In Progress View PDF
2022-04-25 Certified True Copy of Resolution - Annual General Meeting View PDF
2022-04-18 Board Meeting View PDF
2022-04-04 Notice of Annual General Meeting View PDF
2022-04-04 Transmission of Annual Report for the Year Ended 2021-12-31 View PDF
2022-03-30 Prior Publication of AGM Notice for the year 2021 View PDF
2022-02-25 Financial Results for the Year Ended December 31 2021 View PDF
2022-02-18 BOARD OF DIRECTORS MEETING View PDF
2021-12-06 Corporate Briefing Session View PDF
2021-10-29 Transmission of Quarterly Report for the Period Ended September 30, 2021 View PDF
2021-10-25 Financial Results for the Quarter Ended September 30, 2021 View PDF
2021-10-18 Board of Directors Meeting View PDF
2021-09-17 CONVERSION OF PHYSICAL SHARES INTO BOOK ENTRY FORM View PDF
2021-08-27 Transmission of Quarterly Report for the Period Ended 2021-06-30 View PDF
2021-08-23 Financial Results for the Quarter ended June 30, 2021 View PDF
2021-08-20 Board Meeting Reschedule View PDF
2021-08-16 Board of Directors Meeting View PDF
2021-06-01 Appointment of Chief Financial Officer and Executive Director View PDF
2021-05-17 CREDIT OF FINAL CASH DIVIDEND (D-98) FOR THE YEAR ENDED DECEMBER 31, 2020 View PDF
2021-05-04 PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View PDF
2021-04-30 Transmission of Quarterly Report for the Period Ended 2021-03-31 View PDF
2021-04-28 Financial Results for the Quarter ended March 31, 2021 View PDF
2021-04-27 CERTIFIED TRUE COPY OF RESOLUTION View PDF
2021-04-27 MEETING IN PROGRESS View PDF
2021-04-20 Board of Directors Meeting View PDF
2021-04-06 Notice of Annual General Meeting View PDF
2021-04-06 Notice of Annual General Meeting View PDF
2021-04-06 Transmission of Annual Report for the Year Ended 2020-12-31 View PDF
2021-04-05 PRIOR PUBLICATION NOTICE OF ANNUAL GENERAL MEETING View PDF
2021-03-31 Material Information View PDF
2021-03-10 Financial Results for the Year Ended December 31, 2020 View PDF
2021-03-09 GLAXO | GlaxoSmithKline Pakistan Limited PDF
2021-03-02 Board of Directors Meeting View PDF

About Company

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

Address
35 - Dockyard Road, West Wharf, Karachi
Website
www.pk.gsk.com
Key People
Ms. Erum Shakir Rahim CEO
Ms. Lai Kuen Goh Chairman
Mr. Agha Salman Taimur Company Secretary

Page description

GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,ALLSHR,KMIALLSHR,KSE100. GLAXO Share Price / Stock Price is 91.83 PKR. You can also check; Share Price History, GLAXOPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

GLAXO Share Price GLAXO Stock Price GlaxoSmithKline Pakistan Limited psx stock kse100 stock GLAXO Stock Price ALLSHR KMIALLSHR KSE100 Share price History GLAXO Payouts Annoucements Snapshot GLAXO Address GLAXO CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages GLAXO Chairperson GLAXO Secretary GLAXO Website About GLAXO

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.

© 2024 SARMAAYA.PK

Sarmaaya Financials Private Limited is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.